相关实验视频

Updated: Jul 1, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

在肌肉侵入性膀癌中,POLQ确定了对免疫疗法的更好的反应子集,该子集具有高PD-L1的肌肉侵入性膀癌

Ge Liu1, Kaifeng Jin1,2, Zhaopei Liu1,3

  • 1NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Cancer medicine
|March 8, 2024
PubMed
概括

高DNA聚合酶甲基 (POLQ) 和编程细胞死亡连接体1 (PD-L1) 表达预测肌肉侵入性膀癌 (MIBC) 免疫治疗和化疗的反应更好. 这种组合作为预测治疗疗效的优质生物标志物.

关键词:
在PD-L1中.波兰语 波兰语 波兰语免疫疗法 免疫疗法肌肉侵入性膀癌是一种肌肉侵入性膀癌.基于的化学疗法.

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.9K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K